Laboratory Equipment Market size was over USD 37.3 billion in 2026 and is likely to grow at a 7.22% CAGR between 2027 and 2036, crossing USD 74.9 billion by 2036. The industry revenue for 2027 is calculated at USD 39.57 billion.
Government research funding is strengthening the laboratory equipment market by enabling academic institutions, public laboratories, and research centers to upgrade aging infrastructure and adopt more capable analytical systems. Increased allocation toward scientific research, healthcare innovation, life sciences, and advanced technology programs creates opportunities for laboratories to replace outdated instruments with equipment offering improved accuracy, reliability, and throughput. Funding support also facilitates the development of specialized research facilities, where sophisticated analytical, testing, and measurement equipment is required to support increasingly complex experiments. As institutions modernize their laboratory environments, demand expands across equipment categories used for sample preparation, analysis, monitoring, and quality assessment.
The laboratory equipment market is gaining momentum from expanding biotechnology and pharmaceutical research activities, as drug discovery, molecular analysis, formulation development, and quality testing require increasingly sophisticated laboratory capabilities. Greater emphasis on developing novel therapies and improving research productivity is encouraging organizations to equip facilities with instruments capable of handling precise and high-volume analytical workflows. Biotechnology research also involves complex applications such as genomics, proteomics, cell analysis, and biological testing, creating demand for specialized equipment that can support sensitive experimental procedures. Pharmaceutical manufacturers similarly require reliable laboratory systems throughout research and development and quality-control processes, increasing equipment adoption as their research pipelines become more technically demanding.
Integration of automation, robotics, and artificial intelligence is reshaping laboratory operations by reducing manual intervention and enabling more consistent execution of repetitive and complex tasks. For the laboratory equipment market, these technologies are creating demand for connected instruments and automated platforms that can improve sample handling, testing, data processing, and workflow coordination. Robotic systems can perform repetitive procedures with greater consistency, while AI-supported capabilities can assist with data interpretation, anomaly detection, and experimental decision-making. Such integration is particularly valuable for laboratories managing large sample volumes or requiring reproducible results, as automated workflows can reduce operational bottlenecks and allow researchers to devote more time to higher-value scientific activities.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Government research funding driving laboratory infrastructure upgrades and modernization | 2.20% | High | North America, Europe | High | Near Term |
| Expanding biotechnology and pharmaceutical R&D increasing advanced lab equipment demand | 1.80% | Moderate | North America, Europe, Asia Pacific | High | Mid Term |
| Integration of automation, robotics, and AI systems enhancing laboratory workflow efficiency | 1.20% | Moderate | Global | Medium | Mid Term |
North America held the largest share of the laboratory equipment market, accounting for 40.28% in 2026. The region benefits from advanced research infrastructure, strong healthcare and life sciences capabilities, and sustained demand for sophisticated laboratory technologies. Extensive clinical and scientific research activity supports the use of analytical, diagnostic, and testing equipment, while continued investment in laboratory modernization encourages adoption of increasingly efficient and technologically advanced systems. A well-established ecosystem for research and healthcare services further reinforces regional demand.
Asia Pacific is the fastest-growing regional market, supported by expanding healthcare infrastructure, increasing research and development activity, and growing investment in scientific and diagnostic capabilities. The modernization of laboratories across emerging economies is creating opportunities for advanced equipment adoption, while expanding pharmaceutical, biotechnology, and healthcare activities are strengthening demand for reliable testing and analytical technologies. Improvements in research capacity and greater emphasis on healthcare quality are also contributing to broader deployment of laboratory equipment throughout the region.
The U.S. invests in laboratory equipment supporting pharmaceutical development, biotechnology, and advanced scientific research. Laboratories increasingly seek automated, connected instruments that improve operational efficiency and strengthen data management capabilities.
Japan expands laboratory equipment adoption through automation, robotics, and precision analytical technologies. Japanese laboratories prioritize compact, highly reliable systems that improve workflow efficiency while supporting high-quality research and diagnostic activities.
South Korea accelerates laboratory equipment modernization across healthcare, biotechnology, and academic research facilities. Organizations increasingly implement digitally connected laboratory systems that enhance productivity, sample traceability, and analytical performance.
Germany prioritizes laboratory equipment known for precision, reliability, and compliance with demanding research standards. Scientific institutions and industrial laboratories continue upgrading analytical capabilities through advanced instrumentation and digital laboratory solutions.
France strengthens laboratory equipment demand through investments in public research institutions and life sciences innovation. French laboratories prioritize versatile analytical instruments that support multidisciplinary research and evolving diagnostic requirements.
Italy continues upgrading laboratory equipment across healthcare, food testing, environmental analysis, and industrial laboratories. Italian organizations increasingly adopt flexible analytical systems that improve testing efficiency while supporting diverse scientific applications.
The healthcare segment led the laboratory equipment market with a 45.66% share in 2026, supported by the extensive use of laboratory instruments for clinical diagnostics, disease detection, sample analysis, and patient monitoring. Hospitals and healthcare laboratories require reliable equipment to support growing diagnostic workloads and increasingly sophisticated testing procedures. Demand for automation, accurate analytical results, and efficient laboratory workflows is further encouraging investments in modern laboratory infrastructure, sustaining healthcare's leading position.
The veterinary segment is gaining momentum as demand for animal diagnostics and preventive healthcare expands. Increasing awareness of animal health, greater emphasis on early disease detection, and the growing need for laboratory-based testing in veterinary practices are supporting equipment adoption. The broader shift toward more comprehensive veterinary care is also creating opportunities for diagnostic and analytical equipment designed for animal-specific applications.
General laboratory equipment accounted for the largest share of 32.93% in 2026, reflecting its broad applicability across routine laboratory activities. Products used for sample preparation, handling, storage, measurement, and other essential laboratory procedures remain fundamental to healthcare, research, educational, and industrial laboratories. Their widespread use across diverse testing environments and the continuing expansion of laboratory infrastructure provide a stable foundation for this segment.
Analytical laboratory equipment is experiencing faster growth as laboratories increasingly require precise and sophisticated analysis for diagnostics, research, quality control, and scientific development. Greater demand for accurate characterization of samples, automation, and advanced testing capabilities is encouraging the adoption of analytical instruments. The growing complexity of laboratory workflows and increasing emphasis on reliable data-driven results are further supporting this segment's expansion.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| End-use | Research Institutions, Healthcare, Veterinary, Others | Healthcare | Veterinary |
| Product | General, Analytical, Clinical, Support, Specialty | General | Analytical |
1. Thermo Fisher Scientific Inc. (United States)
2. Danaher Corporation (United States)
3. Agilent Technologies Inc. (United States)
4. Sartorius AG (Germany)
5. Bio-Rad Laboratories Inc. (United States)
6. Shimadzu Corporation (Japan)
7. Waters Corporation (United States)
8. Bruker Corporation (United States)
9. FUJIFILM Holdings Corporation (Japan)
10. Revvity Inc. (United States)
Automation and digital laboratory technologies are transforming the laboratory equipment market, with increasing investment in intelligent analytical instruments and workflow optimization. Ongoing research is improving testing accuracy, operational efficiency, and laboratory productivity across scientific and clinical applications.
| Company Name | Date | Key Development |
|---|---|---|
| Pace Life Sciences | Jun-26 | Pace Life Sciences acquired Catalent’s Center-of-Excellence for Small Molecule Analytical Services in North Carolina. This acquisition expands the company’s analytical services network and enhances its capacity in pharmaceutical laboratory testing and contract research support, strengthening its competitive position within the specialized laboratory infrastructure and services segment. |
| Molecular Devices | Jun-26 | Molecular Devices launched a 250 sqm industrial-scale organoids laboratory in Cardiff. The new high-containment facility is designed to support advanced life sciences research workflows and organoid development, significantly expanding the company’s operational footprint in specialized laboratory infrastructure and enhancing its capabilities in supporting controlled, high-precision research environments. |
| Insilico Medicine | Jun-26 | Insilico Medicine integrated a bipedal humanoid AI system into its fully robotic drug discovery laboratory. This deployment facilitates advanced data acquisition, supports the training of embodied AI models, and provides automated laboratory supervision, marking a significant advancement in the automation of experimental research workflows and operational efficiency. |
| Waters Corporation and Sartorius AG | Jun-23 | Waters Corporation and Sartorius AG extended their strategic collaboration to integrate a comprehensive portfolio of bioanalytical solutions for downstream biomanufacturing. This partnership enhances their combined market offering, streamlining laboratory workflows and strengthening their support infrastructure for the biopharmaceutical manufacturing sector through improved analytical integration. |